PRA Health Sciences Inc, founded in 1976 and headquartered in Durham, North Carolina, is a leading global provider of healthcare intelligence and clinical research services. The company specializes in providing comprehensive solutions to pharmaceutical and biotechnology companies, including clinical trial management and drug development services.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| ICLR 2.88% 2026-07-15 USDPRA Health Sciences Inc | United States | 2026-07-15 | 2.875 | 4.84 |
| ICLR 2.88% 2026-07-15 USDPRA Health Sciences Inc | United States | 2026-07-15 | 2.875 | 4.84 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
PRA Health Sciences began issuing bonds in 2012, with significant issuances aimed at strategic acquisitions and expansion of its research capabilities. Notably, their $400 million bond issuance in 2018 was earmarked for refinancing and enhancing their operational flexibility. Current yield levels for PRA's bonds indicate a competitive position within the industry, positioned favorably as the company maintains a robust pipeline of services amid growing demand for clinical research.